Mission: The team of top research scientists at the Institute for Myeloma & Bone Cancer Research utilize years of cumulative expertise and innovative technologies to drive the independent research of the Institute. By using in vitro as well as in vivo research techniques, our scientists have the potential to greatly improve and expand the types of drugs for patients with these diseases as well as rapidly lead to many clinical trials to achieve our mission.
Results: Our team understands the science and how to apply it to patients. We have amassed decades of experience in our ability to outsmart the disease and find inroads to fight these cancers on many innovative levels. The motivation to build the Institute for Myeloma & Bone Cancer Research comes from the core belief that a dedicated, stand-alone organization can accelerate the advancement of scientific research and ultimately help grant millions of people freedom from the symptoms of these devastating diseases.
Programs: Achieved advancements in the research and cure for myeloma. Research has helped cure or reduce the occurrence of myeloma in humans.
IMBCR is an extremely professional, results-oriented research laboratory with an imperative to cure multiple myeloma. This is not just research for research's sake---they have their eye on the ball and are constantly advancing towards curative therapy. Helmed by Dr. Berenson, IMBCR is adjacent to his clinic where many patients are seen daily. This unique combination of a real-world practice, adjacent to a world-class research facility--has so many excited for the breakthroughs that have already sprung forth, and those that are imminent.